Rajinder Singh MD
About Rajinder Singh MD
Rajinder Singh MD is a Senior Drug Safety Physician (Senior Director) at Bristol Myers Squibb with over 13 years of experience in drug safety and development.
Title and Current Role
Rajinder Singh MD serves as the Senior Drug Safety Physician (Senior Director) for Global Drug Development at Bristol Myers Squibb. In his role, he leads the global safety operations and plays a crucial role in overseeing drug safety assessments and regulations.
Education and Medical Training
Rajinder Singh completed his Doctor of Medicine (MD) and Residency in Anesthesiology & Critical Care at Medical School. His solid foundation in medical science and critical care established the basis for his career in drug safety and development.
Experience in Drug Safety and Development
With over 13 years of professional experience, Rajinder Singh has extensive expertise in drug safety and development. His diverse background includes responsibilities as Global Safety Lead (GSL) for three drug molecules under development, with one currently undergoing NDA submission.
Committee Memberships
Rajinder Singh is an active member of the Safety Review Committee (SRC) and the Benefit-Risk Assessment Committee (BRAC) at Bristol Myers Squibb. These roles involve crucial decision-making processes to ensure the safety and efficacy of pharmaceutical products.
Professional Contributions and Leadership
Rajinder Singh has been instrumental in developing pharmacovigilance (PV) departments from the ground up in two separate pharmaceutical companies. He has also been recognized for his strategic planning and budgetary management. Additionally, he founded the West Coast Drug Safety Physicians' Forum, facilitating professional dialogue and problem-solving among safety physicians.